World

US Regulators Deal Blow to Chinese Biotech With Cancer Drug Rejection

RecentNews.uk

01

US FDA rejects the lung cancer drug ivonescimab

02

Drug was invented in China by partner firm Akeso

03

Clinical trial data failed to meet crucial survival goals

04

Decision represents a major hurdle for Beijing's biotech export ambitions

Reader poll

Will Chinese biotech firms overcome these Western regulatory hurdles within the next five years?

Tap below to vote and see what others think.

Read the full story